Animal models of anxiety and anxiolytic drug action

Current Topics in Behavioral Neurosciences

Volumn 2, Issue , 2010, Pages 121-160

  Treit, Dallas ^a   Engin, Elif ^a   McEown, Kris ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Animal models; Antidepressant; Anxiety; Anxiolytic; Biological validity; Construct validity; Drug receptors; Face validity

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CHLORDIAZEPOXIDE; CLONAZEPAM; DESIPRAMINE; DIAZEPAM; FLUNITRAZEPAM; IMIPRAMINE; IPRONIAZID; MIANSERIN; PARGYLINE; PHENELZINE; SEROTONIN 1A AGONIST; TRAZODONE; SEROTONIN 1 AGONIST;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; BRAIN FUNCTION; CHRONIC DRUG ADMINISTRATION; CONDITIONING; CONSTRUCT VALIDITY; DISEASE CONTROL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SCREENING; DRUG SENSITIVITY; ENZYME INHIBITION; EXPERIMENTAL ANIMAL; FACE VALIDITY; FALSE POSITIVE RESULT; FEAR; HUMAN; LIGHT DARK CYCLE; LOCOMOTION; LONG TERM CARE; MAZE TEST; MEDICAL RESEARCH; MOOD DISORDER; NONHUMAN; PANIC; PATHOGENESIS; PHARMACOLOGICAL PARAMETERS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; SOCIAL INTERACTION; SYMPTOMATOLOGY; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE; VALIDATION PROCESS; ANIMAL; DRUG EFFECT; EXPLORATORY BEHAVIOR; HUMAN RELATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; STARTLE REFLEX; TREATMENT OUTCOME;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEAR; GABA-A RECEPTOR AGONISTS; HUMANS; INTERPERSONAL RELATIONS; MAZE LEARNING; NEUROPSYCHOLOGICAL TESTS; SEROTONIN 5-HT1 RECEPTOR AGONISTS; STARTLE REACTION; TREATMENT OUTCOME;

EID: 79952255753     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2009_17     Document Type: Review

References (359)

1. Adamec R, Bartoszyk GD, Burton P (2004) Effects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats. Eur J Pharmacol 504:65-77
2. Albrechet-Souza L, Oliveira AR, De Luca MC et al (2005) A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia. Prog Neuropsychopharmacol Biol Psychiatry 29(4):571-579
3. Albrechet-Souza L, de Carvalho MC, Franci CR, Brandao ML (2007) Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm Behav 52:267-273
4. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, (DSM-IVTM), 4th edn. American Psychiatric Association, Washington, DC
5. Anuradha H, Srikumar BN, Rao BSS et al (2008) Euphorbia hirta reverses chronic stress-induced anxiety and mediates its action through the GABA(A) receptor benzodiazepine receptor-clchannel complex. J Neural Transm 115:35-42
6. Argyropoulos SV, Sandford JJ, Nutt D (2000) The psychobiology of anxiolytic drugs Part 2: pharmacological treatments of anxiety. PharmacolTher 88:213-227
7. Aricioglu F, Altunbas H (2003) Agmatine an endogenous anxiolytic. Agmatine and imidazolines: Their novel receptors and enzymes. 1009:136-140
8. Atack JR, Pike A, Marshall G et al (2006) The in vivo properties of pagoclone in rat are most likely mediated by 50-hydroxy pagoclone. Neuropharmacology 50:677-689
9. Baldwin HA, Johnston AL, File SE (1989) Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol 159:211-215
10. Ballard TM, Woolley ML, Prinssen E et al (2005) The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology (Berl) 179:218-229
11. Bartoszyk GD, Hegenbart R, Ziegler H (1997) EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties. Eur J Pharmacol 322:147-153
12. Beardslee SL, Papadakis E, Fontana DJ et al (1990) Antipanic drug treatments: failure to exert anxiolytics-like effects on defensive burying behavior. Pharmacol Biochem Behav 35:451-455
13. Becker C, Thiebot MH, Touitou Y et al (2001) Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat. J Neurosci 21:262-269
14. Berg WK, Davis M (1984) Diazepam blocks fear-enhanced startle elicited electrically from the brain-stem. Physiol Behav 32:333-336
15. Bhattacharya SK, Bhattacharya A, Sairam K et al (2000) Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine 7:463-469
16. Bill DJ, Fletcher A, Knight M (1989) Actions of 5HT1A ligands and standard anxiolytics on mouse exploratory behaviour in a two compartment light: dark arena. Br J Pharmacol 98 (Suppl):679
17. Blampied NM, Kirk RC (1983) Defensive burying: effects of diazepam and oxprenolol measured in extinction. Life Sci 33:695-699
18. Blanchard RJ, Blanchard DC, Agullana R et al (1991) 22 kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems. Physiol Behav 50:967-972
19. Blumberg MS, Sokoloff G, Kirby RF et al (2000) Distress vocalizations in infant rats: what's all the fuss about? Psychol Sci 11:78-81
20. Bojarski AJ, Paluchowska MH, Duszynska B et al (2006) Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl) cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic-like activity. Bioorg Med Chem 14:1391-1402
21. Bondi CO, Barrera G, Lapiz MDS et al (2007) Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Prog Neuro-psychopharmacol Biol Psychiat 31:482-495
22. Borsini F, Podhorna J, Marazziti D (2002) Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology 163:121-141
23. Both FL, Meneghini L, Kerber VA et al (2005) Psychopharmacological profile of the alkaloid psychollatine as a 5HT2(A. J Nat Prod 68:374-380
24. Bourin M, Hascoet M (2003) The mouse light/dark box test. Eur J Pharmacol 463:55-65
25. Bourin M, Redrobe JP, Hascoet M et al (1996) A schematic representation of the psychopharmacological profile of antidepressants. Prog Psychopharmacol Biol Psychiat 20:1389-1402
26. Bourin M, Petit-Demouliere B, Dhonnchadha BN et al (2007) Animal models of anxiety in mice. Fundam Clin Pharm 21:567-574
27. Bradley BF, Starkey NJ, Brown SL et al (2007) The effects of prolonged rose odor inhalation in two animal models of anxiety. Physiol Behav 92:931-938
28. Bristow LJ, O'Connor D, Watts R et al (2000) Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100, 635, in the rat. Neuropharmacology 39:1222-1236
29. Brocco MJ, Koek W, Degryse AD et al (1990) Comparative studies on the anti-punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and Vogel conflict procedures. Behav Pharmacol 1:403-418
30. Brodkin J, Busse C, Sukoff SJ et al (2002) Anxiolytic-like activity of the mGluR5 antagonist MPEP-a comparison with diazepam and buspirone. Pharmacol Biochem Behav 73:359-366
31. Broekkamp CL, Rijk HW, Joly-Gelouin D et al (1986) Major tranquilizers can be distinguished from minor tranquilizers on the basis of effects on marble-burying and swim-induced grooming in mice. Eur J Pharmacol 126:223-229
32. Brown JS, Kalish HI, Farber IE (1951) Conditioned fear as revealed by magnitude of startle response to an auditory stimulus. J Exp Psychol 41:317-328
33. Burgdorf J, Panksepp J (2006) The neurobiology of positive emotions. Neurosci Biobehav Rev 30:173-187
34. Busse CS, Brodkin J, Tattersall D et al (2004) The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 29:1971-1979
35. Byrnes EM, Bridges RS (2006) Reproductive experience reduces the sedative, but not anxiolytic effects of diazepam. Psychoneuroendocrinology 31:988-996
36. [3H]-ketanserin binding. Neurosci Lett 42(Suppl):S8
37. Caille D, Bergis OE, Fankhauser C et al (1996) Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. ll. Pharmacological profile. J Pharmacol Exp Ther 277:265-277
38. Caliendo G, Santagada V, Perissutti E et al (2005) Derivatives as 5HT(1A) receptor ligands-past and present. Curr Med Chem 12:1721-1753
39. Cao BJ, Rodgers RJ (1997) Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze. Neuropharmacology 36:1089-1097
40. Carden SE, Hofer MA (1990) Independence of benzodiazepine and opiate action in the suppression of isolation distress in rat pups. Behav Neurosci 104:160-166
41. Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193-1205
42. Carr MN, Bekku N, Yoshimura H (2006) Identification of anxiolytic ingredients in ginseng root using the elevated plus-maze test in mice. Eur J Pharmacol 531:160-165
43. Casella JV, Davis M (1985) Fear enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology (Berl) 87:4
44. Cechin EM, Quevedo J, Barichello T et al (2003) Dose-related effects of propericiazine in rats. Braz J Med Biol Res 36(2):227-231
45. Cha HY, Park JH, Hong JT et al (2005) Anxiolytic-like effects of ginsenosides on the elevated plus-maze model in mice. Biol Pharm Bull 28:1621-1625
46. Chaki S, Oshida Y, Ogawa S et al (2005) MCL0042: a nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic-and antidepressant-like activity. Pharmacol Biochem Behav 82:621-626
47. Cheeta S, Irvine E, File SE (2001) Social isolation modifies nicotine's effects in animal tests of anxiety. Br J Pharmacol 132:1389-1395
48. Chen SW, Mi XJ, Wang R et al (2005) Behavioral effects of sinomenine in murine models of anxiety. Life Sci 78:232-238
49. Chen SW, Wang WJ, Li WJ et al (2006) Anxiolytic-like effect of asiaticoside in mice. Pharmacol Biochem Behav 85:339-344
50. Chi CC (1965) Effect of amobarbital sodium on conditioned fear as measured by potentiated startle response in rats. Psychopharmacologia 7:115-122
51. Clénet F, Hascoët M, Fillion G et al (2004) Anxiolytic profile of HG1, a 5-HT-moduline antagonist, in three mouse models of anxiety. Eur Neuropsychopharmacol 14(6):449-456
52. Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology (Berl) 114:288-296
53. Cole JC, Rodgers RJ (1995) Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473-478
54. Collinson N, Dawson GR (1997) On the elevated plus-maze the anxiolytic-like effects of the 5-HT1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635. Psychopharmacology (Berl) 132:35-43
55. Commissaris RL, Hill RJ (1995) High-dose subchronic imipramine treatment: effects on anxietylike (conflict) behavior in rats. Anxiety 1:109-113
56. Commissaris RL, Ellis DM, Hill TJ et al (1990) Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat. Pharmacol Biochem Behav 37:167-176
57. Commissaris RL, Humrich J, Johns J et al (1995) The effects of monoamine oxidase (MAO) inhibitors on conflict behavior in the rat. Behav Pharmacol 6:195-202
58. Commissaris RL, Fomum EA, Leavell BJ (2004) Effects of buspirone and alprazolam treatment on the startle-potentiated startle response. Depress Anxiety 19:146-151
59. Costa M, Costa CRA, Gargano AC et al (2006) Differential behaviour in the marble-burying test does not predict behavioural differences in generalized anxiety disorder models. Eur Neuropsychopharmacol 16:S474-S475
60. Costall B, Hendrie CA, Kelly ME et al (1987) Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology 26:5
61. Costall B, Domeney AM, Grrard PA et al (1988a) Zacopride: anxiolytic profile in rodent and primate models of anxiety. J Pharm Pharmacol 40:3
62. Costall B, Kelly ME, Naylor RJ et al (1988b) Actions of buspirone in a putative model of anxiety in the mouse. J Pharm Pharmacol 40:6
63. Costall B, Jones BJ, Kelly ME et al (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:8
64. Costall B, Domeney AM, Farre AJ et al (1992) Profile of action of a novel 5-hydroxytriptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset. J Pharmacol Exp Ther 262:8
65. Costanzo A, Guerrini G, Ciciani G et al (2002) Benzodiazepine receptor ligands. 7. Synthesis and pharmacological evaluation of new 3-esters of the 8-chloropyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide. 3-(2-thienylmethoxycarbonyl) derivative: an anxioselective agent in rodents. J Med Chem 45:5710-5720
66. Costello NL, Carlson JN, Glick SD (1991) Acute administration of diazepam and buspirone in rats trained on conflict schedules having different degrees of predictability. Pharmacol Biochem Behav 40:787-794
67. Craft RM, Howard JL, Pollard GT (1988) Conditioned defensive burying as a model for identifying anxiolytics. Pharmacol Biochem Behav 30:775-780
68. Crawley JN (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15:4
69. Crawley JN, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:3
70. Critchley MAE, Handley SL (1987a) 5-HT 1A ligand effects in the X-maze anxiety test. Br J Pharmacol 92:660P
71. Critchley MAE, Handley SL (1987b) Effects in the X-maze model of agents acting at 5-HT 1 and 5-HT 2 receptors. Psychopharmacology (Berl) 93:502-506
72. Cronbach LJ, Meehl PE (1955) Construct validity in psychological tests. Psychol Bull 52:281-302
73. Cryan JF, Holmes A (2005) the ascent of mouse: advances in modelling human depression and anxiety. Nat Rev 4:775-790
74. Cryan JF, Kelly PH, Chaperon F et al (2004) Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N, N0-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310(3):952-963
75. Cui XY, Zhao X, Chu QP et al (2007) Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test. J Neural Transm 114:155-160
76. Cutler MG (1991) An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behavior during social interactions in female and male mice. Neuropharmacology 30:7
77. Dal-Cól ML, Pereira LO, Rosa VP et al (2003) Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacol Biochem Behav 74:395-400
78. Davis M (1979) Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology 62:7
79. Davis M (1986a) Neural mechanisms of fear conditioning measured with the acoustic startle reflex. Pharmacol Biochem Behav 25:312
80. Davis M (1986b) Pharmacological and anatomical analysis of fear conditioning using the fearpotentiated startle paradigm. Behav Neurosci 100:814-824
81. Davis M, Kehne JH, Commissaris RL (1985) Antagonism of apomorphine-enhanced startle by alpha-1-adrenergic antagonists. Eur J Pharmacol 108:233-241
82. Davis M, Cassella JV, Kehne JH (1988) Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology (Berl) 94:14-20
83. De Angelis L (1992) The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate. Methods Find Exp Clin Pharmacol 14:767-771
84. De Angelis L, Furlan C (2000) The anxiolytic like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test. Pharmacol Biochem Behav 65:649-653
85. De Boer SF, Slangen JL, van der Gugten J (1990) Plasma catecholamine and corticosterone levels during active and passive shock-prod avoidance behavior in rats: effects of chlordiazepoxide. Pharmacol Biochem Behav 47:1089-1098
86. de Jongh R, Groenink L, van der Gugten J et al (2002) The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine. Psychopharmacology 159:176-180
87. De Vry J, Schreiber R, Melon C et al (2004) 5-HT1A receptors are differentially involved in the anxiolytic-and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 14:487-495
88. Degroot A, Nomikos GG (2004) Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test. Eur J Neurosci 20:1059-1064
89. Dekeyne A, Brocco M, Adhumeau A et al (2000) The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. Psychopharmacology (Berl) 152:55-66
90. Deren-Wesolek A, Tatarczynska E, Chojnacka-Wojcik E (1998) The novel buspirone analogue, 8-[4-[2-(1, 2, 3, 4-tetrahydroisoquinolinyl)[butyl]-8-azaspiro]decane-7, 9-dione, with anxiolytic-like and antidepressant-like effects in rats. J Psychopharmacology (Berl) 12:380-384
91. DeVry J, Benz U, Schreiber R et al (1993) Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety agents. Eur J Pharmacol 249:331-339
92. Drapier D, Bentue-Ferrer D, Laviolle B et al (2007) Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 176:202-209
93. Dunn RW, Corbett R, Fielding S (1989) Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169:10
94. Duxon MS, Starr KR, Upton N (2000) Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635. Br J Pharmacol 130:1713-1719
95. Eguchi J, Inomata Y, Saito K (2001) The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism. Pharmacol Biochem Behav 68:677-683
96. Ellis DM, Fontana DJ, McCloskey C et al (1990) Chronic anxiolytic treatment effects on conflict behavior in the rat. Pharmacol Biochem Behav 37:177-186
97. Engin E, Treit D (2008) The effects of intra-cerebral drug infusions on animals' untrained fear reactions: a systematic review. Prog Neuro-Psychopharmacol Biol Psychiat 32(6):1399-1419
98. Escarabajal MD, Torres C, Flaherty CF (2003) The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone. Life Sci 73:1063-1074
99. Felipe FCB, Sousa JT, Souza LEDO et al (2007) Piplartine, an amide alkaloid from piper tuberculatum, presents anxiolytic and antidepressant effects in mice. Phytomedicine 14: 605-612
100. Fernandez-Guasti A, Lopez-Rubalcava C (1998) Modification of the anxiolytic action of 5-HT1A compounds by GABA-benzodiazepine agents in rats. Pharmacol Biochem Behav 60:27-32
101. Fernandez-Guasti A, Martinez-Mota L (2003) Orchidectomy sensitizes male rats to the action of diazepam on burying behavior latency: role of testosterone. Pharmacol Biochem Behav 75:473-479
102. Fernandez-Guasti A, Picazo O (1990) The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase. Pharmacol Biochem Behav 37:77-81
103. Fernandez-Guasti A, Picazo O (1997) Anxiolytic action of diazepam, but not of buspirone, are influenced by gender and the endocrine stage. Behav Brain Res 88:213-218
104. Fernandez-Guasti A, Hong E, Lopez-Rubalcava C (1992) Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action. Psychopharmacology (Berl) 107:61-68
105. Fernandez-Guasti A, Martinez-Mota L, Estrada-Camerena E et al (1999) Chronic treatment with desipramine induces an estrous cycle-dependent anxiolytic-like action in the burying behavior, but not in the elevated plus maze test. Pharmacol Biochem Behav 63:13-20
106. Fernandez-Guasti A, Ferreira A, Picazo O (2001) Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats. Pharmacol Biochem Behav 70:85-93
107. Fernández-Guasti A, Reyes R, Martínez-Mota L et al (2005) Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats. Psychopharmacology (Berl) 180(3):399-407
108. File SE (1980) The use of social interaction as a model of detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Meth 2:219-238
109. File SE (1985) Animal models for predicting clinical efficacy of anxiolytic drugs: social behavior. Neuropsychobiology 13:7
110. File SE, Hyde JRG (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:5
111. File SE, Hyde JRG (1979) A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and stimulants. Pharmacol Biochem Behav 11:4
112. File SE, Johnston AL (1987) Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat. Neuropsychobiology 17:187-192
113. File SE, Pellow S (1985) The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br J Pharmacol 86:729-735
114. File SE, Ouagazzal AM, Gonzalez LE et al (1999) Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function. Pharmacol Biochem Behav 62:695-701
115. File SE, Cheeta S, Akanezi C (2001) Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action. Brain Res 888:311-313
116. Finn DA, Rutledge-Gorman MT, Crabbe JC (2003) Genetic animal models of anxiety. Neurogenetics 4:109-135
117. Fish EW, Sekinda M, Ferrari PF et al (2000) Distress vocalizations in maternally separated mouse pups: modulation via 5-HT1A, 5-HT1B and GABA(A) receptors. Psychopharmacology 149:277-285
118. Fish EW, Faccidomo S, Gupta S et al (2004) Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups. J Pharmacol Exp Ther 308:474-480
119. Fontana DJ, Commissaris RL (1988) Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder? Psychopharmacology (Berl) 95:147-150
120. Fontana DJ, Carbary TM, Commissaris RL (1989) Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology (Berl) 98:157-162
121. Gardner CR (1986) Recent developments in 5-HT-related pharmacology of animal models of anxiety. Pharmacol Biochem Behav 24:1479-1485
122. Gardner CR, Guy AP (1984) A social interaction model of anxiety sensitive to accutely administered benzodiazepines. Drug Dev Res 4:207-216
123. Giusti R, Guidetti G, Costa E et al (1991) The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action. J Pharmacol Exp Ther 257:1062-1068
124. Gleason SD, Witkin JM (2007) A parametric analysis of punishment frequency as a determinant of the response to chlordiazepoxide in the Vogel conflict test in rats. Pharmacol Biochem Behav 87:380-385
125. Gomez C, Saldivar-Gonzalez A, Delgado G, Rodriguez R (2002) Rapid anxiolytic activity of progesterone and pregnanolone in male rats. Pharmacol Biochem Behav 72:543-550
126. Gonzalez-Pardo H, Conejo NM, Arias JL (2006) Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam and zolpidem. Prog Neuropsychopharmacol Biol Psychiatry 30:1020-1026
127. Gonzalez-Trujano E, Martinez AL, Reyes-Ramirez A et al (2006) Palmitone isolated from annona diversifolia induces an anxiolytic-like effect in mice. Planta Med 72:703-707
128. Graeff FG, Audi EA, Almeida SS et al (1990) Behavioral effects of 5-HT receptor ligands in the aversive brain stimulation, elevated plus-maze and learned helplessness tests. Neurosci Biobehav Rev 14:501-506
129. Griebel G, Moreau JL, Jenck F et al (1994) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113:463-470
130. Griebel G, Sanger DJ, Perrault G (1996) The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega) (1) selective, benzodiazepine receptor ligands. Psychopharmacology (Berl) 124:245-254
131. Griebel G, Rodgers RJ, Perrault G et al (1997) Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacol Biochem Behav 57:817-827
132. Griebel G, Cohen C, Perrault G et al (1999) Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiol Behav 67:315-320
133. Groenink L, Van der Gugten J, Verdouw PM et al (1995) The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects. Eur J Pharmacol 280:185-193
134. Groenink L, Van Der Gugten J, Compaan JC et al (1997) Felsinoxan pretreatment differentially affects corticosterone, prolactin and behavioral responses to a flesinoxan challenge. Psychopharmacology (Berl) 131:93-100
135. Grundmann O, Nakajima JI, Seo S et al (2007) Anti-anxiety effects of apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol 110:406-411
136. Guy AP, Gardner CR (1985) Pharmacological characterisation of a modified social interaction model in rat. Neuropsychobiology 13:194-200
137. Gyertyan I (1995) Analysis of the marble burying response: marbles serve to measure digging rather than evoke burying. Behav Pharmacol 6:24-31
138. Hagenbuch N, Feldon J, Yee BK (2006) Use of the elevated plus-maze test with opaque or transparent walls in the detection of mouse strain differences and the anxiolytic effects of diazepam. Behav Pharmacol 17:31-41
139. Hallar J, Hallasz J, Makara GB (2000) Housing conditions and the anxiolytic effect of buspirone: the relationship between main and side effects. Behav Pharmacol 11:9
140. Haller J, Bakos N (2002) Stress-induced social avoidance: a new model of stress-induced anxiety? Physiol Behav 77:327-332
141. Haller J, Leveleki C, Halasz J et al (2001) The effect of glucocorticoids on the anxiolytic efficacy of buspirone. Psychopharmacology 157:388-394
142. Haller J, Leveleki C, Baranyi J et al (2003) Stress, social avoidance and anxiolytics: a potential model of stress-induced anxiety. Behav Pharmacol 14:439-446
143. Handley SL, McBlane JW (1992) Opposite effects of fluoxetine in two animal models of anxiety. Br J Pharmacol 107(Suppl):446P
144. Handley SL, Mithani S (1984) Effects of alpha-adrenoreceptor agonists and antagonists in a Xmaze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharm 327:1-5
145. Harasawa T, Ago Y, Itoh S et al (2006) Role of serotonin type 1A receptors in fluvoxamineinduced inhibition of marble-burying behavior in mice. Behav Pharmacol 17:637-640
146. Hascoet M, Bourin M (1997) Anticonflict effect of alpidem as compared with the benzodiazepine alprazolam in rats. Pharmacol Biochem Behav 56:317-324
147. Hascoet M, Bourin M (1998) A new approach to the light/dark procedure in mice. Pharmacol Biochem Behav 60:645-653
148. Hascoet M, Bourin M, Dhonnchadha A (2000) The influence of buspirone and its metabolite1-PP on the activity of paroxetine in the mouse light dark paradigm and four plates test. Pharmacol Biochem Behav 67:45-53
149. Hendrie EA, Eilam D, Weiss SM (1997) Effects of diazepam and buspirone on the behaviour of wild voles (microtus socialis) in two models of anxiety. Pharmacol Biochem Behav 58: 573-576
150. Hijzen TH, Slangen JL (1989) Effects of midazolam, DMCM and lindane on potentiated startle in the rat. Psychopharmacology (Berl) 99:3
151. Hijzen TH, Houtzager SW, Joordens RJ et al (1995) Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs. Psychopharmacology (Berl) 118:150-154
152. Hodgson RA, Guthrie DH, Varty GB (2008) Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs. Pharmacol Biochem Behav 88:341-348
153. Hoffman EJ, Mathew SJ (2008) Anxiety disorders: a comprehensive review of pharmacotherapies. Mt Sinai J Med 75:248-262
154. Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21-30
155. Holmes A, Rodgers RJ (2003) Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Eur J Pharmacol 459:221-230
156. Howard JL, Pollard GT (1990) Effects of buspirone in the Geller-Seifter conflict test with incremental shock. Drug Dev Res 19:37-47
157. Huen MS, Hui KM, Leung JW et al (2003) Naturally occurring 20-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands. Biochem Pharmacol 66:2397-2407
158. Ichimaru Y, Egawa T, Sawa A (1995) 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble burying behavior in mice. Jpn J Pharmacol 68:65-70
159. Igor BA, Santucci D, Alleva E (2001) Ultrasonic vocalizations emitted by infant rodents: a tool for assessment of neurobehavioural development. Behav Brain Res 125:49-56
160. Iijima M, Chaki S (2005) Separation-induced ultrasonic vocalization in rat pups: further pharmacological characterization. Pharmacol Biochem Behav 82:652-657
161. Imaizumi M, Miyazaki S, Onodera K (1994a) Effects of xanthine derivatives in a light/dark test in mice and contribution of adenosine receptors. Methods Find Exp Clin Pharmacol 16:639-644
162. Imaizumi M, Suzuki T, Machida H et al (1994b) A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice. Jpn J Psychopharmacol 14:83-91
163. Insel TR, Hill JL, Mayor RB (1986) Rat pup ultrasonic isolation calls: possible mediation by the benzodiazepine receptor complex. Pharmacol Biochem Behav 24:1262-1267
164. Johnston AL, File SE (1988) Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety. Psychiat Res 25:9
165. Johnston AL, File SE (1989) Yohimbine's anxiogenic action; evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav 32:151-156
166. Jones GH, Schneider C, Schneider HH et al (1994) Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies. Psychopharmacology (Berl) 114:191-199
167. Joordens RJ, Hijzen TH, Peeters BW et al (1996) Fear potentiated startle response is remarkably similar in two laboratories. Psychopharmacology (Berl) 126:5
168. Joordens RJ, Hijzen TH, Olivier B (1998) The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear potentiated startle response. Psychopharmacology (Berl) 139:7
169. Jung JW, Ahn NY, Oh HR et al (2006) Anxiolytic effects of the aqueous extract of uncaria rhynchophylla. J Ethnopharmacol 108:193-197
170. Jurczyk S, Kołaczkowski M, Maryniak E et al (2004) New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2, 1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. J Med Chem 47:2659-2666
171. Kaltwasser MT (1990) Acoustic startle induced ultrasonic vocalization in the rat-a novel animalmodel of anxiety. Psychopharmacology 101:s28-s28
172. Kaltwasser MT (1991) Acoustic startle induced ultrasonic vocalization in the rat-a novel animalmodel of anxiety. Behav Brain Res 43:133-137
173. Kantor S, Jakus R, Molnar E et al (2005) Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra. J Pharmacol Exp Ther 315:921-930
174. Kapus GL, Gacsályi I, Vegh M et al (2008) Antagonism of AMPA receptors produces anxiolyticlike behavior in rodents: effects of GYKI 52466 and its novel analogues. Psychopharmacology (Berl) 198:231-241
175. Kaufmann WA, Humpel C, Alheid GF et al (2003) Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action. Brain Res 964:91-99
176. Kehne JH, Casella JV, Davis M (1988) Anxiolytic effects of buspirone and gepirone in the fear potentiated startle paradigm. Psychopharmacology (Berl) 94:5
177. Kehne JH, Coverdale S, McCloskey TC et al (2000) Effects of the CRF, receptor antagonist, CP 154, 526, in the separation-induced vocalization anxiolytic test in rat pups. Neuropharmacology 39:1357-1367
178. Kennett GA, Trail B, Bright F (1998) Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Neuropharmacology 37:1603-1610
179. Kilfoil T, Michel A, Montgomery D et al (1989) Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology 28:5
180. Kim WK, Jung JW, Ahn NY et al (2004) Anxiolytic-like effects of extracts from albizzia julibrissin bark in the elevated plus-maze in rats. Life Sci 75:2787-2795
181. Kita A, Furukawa K (2008) Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice. Pharmacol Biochem Behav 89:171-178
182. Klein DF (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5:397-408
183. Kłodzińska A, Tatarczyńska E, Stachowicz K et al (2004) The anxiolytic-like activity of AIDA (1-aminoindan-1, 5-dicarboxylic acid), an mGLu 1 receptor antagonist. J Physiol Pharmacol 55 (1 Pt 1):113-126
184. Knapp DJ, Pohorecky LA (1995) An air-puff stimulus method for elicitation of ultrasonic vocalizations in rats. J Neurosci Methods 62:1-5
185. Koks S, Beljajev S, Koovit I et al (2001) 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology (Berl) 153:365-372
186. Korte SM, Bohus B (1990) The effect of ipsapirone on behavioral and cardiac responses in the shock probe defensive burying test in male rats. Eur J Pharmacol 181:307-310
187. Korte SM, De Boer SF (2003) A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 463:163-175
188. Kuan WL, Zhao JW, Barker RA (2008) The role of anxiety in the development of levodopainduced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. Psychopharmacology 197:279-293
189. Kumar S, Sharma A (2005) Anti-anxiety activity studies on homoeopathic formulations of turnera aphrodisiaca ward. Evid-Based Complement Alternat Med 2:117-119
190. Kurt M, Arik AC, Celik S (2000) The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice. J Basic Clin Physiol Pharmacol 11:173-180
191. Kurt M, Bilge SS, Kukula O, Celik S, Kesim Y (2003) Anxiolytic-like profile of propofol, a general anesthetic, in the plus-maze test in mice. Pol J Pharmacol 55(6):973-977
192. Lapiz-Bluhm MD, Bondi CO, Doyen J, Rodriguez GA, Bédard-Arana T, Morilak DA (2008) Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J Neuroendocrinol 20:1115-1137
193. Leveleki C, Sziray N, Levay G et al (2006) Pharmacological evaluation of the stress-induced social avoidance model of anxiety. Brain Res Bull 69:153-160
194. Li X, Morrow D, Witkin JM (2006) Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying. Life Sci 78:1933-1939
195. Liao JF, Hung WY, Chen CF (2003) Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. Eur J Pharmacol 464:141-146
196. Lightowler S, Kennett GA, Williamson I et al (1994) Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol Biochem Behav 49:4
197. Lin YC, Hsieh MT, Chen CF et al (2003) Anxiolytic effect of ting-chih-wan in mouse behavior models of anxiety. Am J Chin Med 31:47-59
198. Linnoila M, Eckardt M, Durcan M et al (1987) Interactions of serotonin with ethanol: clinical and animal studies. Psychopharmacol Bull 23:452-457
199. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92:180-185
200. Lopez-Rubalcava C (1996) Pre-or post-synaptic activity of 5-HT1A compounds in mice depends on the anxiety paradigm. Pharmacol Biochem Behav 54:677-686
201. Lopez-Rubalcava C, Saldivar A, Fernandez-Guasti A (1992) Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics. Pharmacol Biochem Behav 43:433-440
202. Lopez-Rubalcava C, Fernandez-Guasti A, Urba-Holmgren R (1996) Age dependant differences in the rat conditioned defensive burying behavior: effect of 5-HT1A compounds. Dev Psychobiol 29:157-169
203. Lopez-Rubalcava C, Crus SL, Fernandez-Guasti A (1999) Blockade of the anxiolytic like action of ipsapirone and buspirone, but not that of 8-OH-DPAT, by adrenalectomy in male rats. Psychoneuroendocrinology 24:409-422
204. Louis C, Stemmelin J, Boulay D et al (2008) Additional evidence for anxiolytic-and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models. Pharmacol Biochem Behav 89:36-45
205. Low K, Crestani F, Keist R et al (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134
206. Luscombe GP, Mazurkiewicz SE, Buckett WR (1990) Evaluation of tricyclic antidepressants in the elevated plus-maze in rats: anxiolytic effects of dothiepin and doxepine. Br J Pharmacol 100(Suppl):356P
207. Luszczki JJ (2008) Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazoleinduced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves. Naunyn-Schmiedeberg's Arch Pharmacol 378:483-492
208. Maisonnette S, Morato S, Brandao ML (1993) Role of resocialization and of 5-HT1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze test. Physiol Behav 54:753-758
209. Majercsik E, Haller J, Leveleki C et al (2003) The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men. Prog Neuro-Psychopharmacol Biol Psychiat 27:1187-1199
210. Mansbach RS, Geyer MA (1988) Blokade of potentiated startle responding in rat by 5-hydroxytriptamine-1A receptor ligands. Eur J Pharmacol 156:8
211. Marowsky A, Fritschy JM, Vogt KE (2004) Functional mapping of GABA(A) receptor subtypes in the amygdala. Eur J Neurosci 20:1281-1289
212. Martin JR, Ballard TM, Higgins GA (2002) Influence of the 5-HT2C receptor antagonist, S13-242084, in tests of anxiety. Pharmacol Biochem Behav 71:615-625
213. Martinez-Mota L, Estrada-Camarena E, Lopez-Rubalcava C et al (2000) Interaction of desipramine with steroid hormones on experimental anxiety. Psychoneuroendocrinology 25:109-120
214. Martins AP, Marras RA, Guimaraes FS (2000) Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray. Depress Anxiety 12:99-101
215. Mathiasen L, Mirza NR (2005) A comparison of chlordiazepoxide, bretazenil, L838, 417 and zolpidem in a validated mouse Vogel conflict test. Psychopharmacology (Berl) 182:475-484
216. Mathiasen LS, Mirza NR, Rodgers RJ (2008) Strain-and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice. Pharmacol Biochem Behav (in press)
217. Matsuzawa-Yanagida K, Narita M, Nakajima M et al (2008) Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology 33:1952-1965
218. Matuszewich L, Karney JJ, Carter SR, Janasik SP, O'Brien JL, Friedman RD (2007) The delayed effects of chronic unpredictable stress on anxiety measures. Physiol Behav 90:674-681
219. McCloskey TC, Paul BK, Commissaris RL (1987) Buspirone effects in an animal conflict procedure: comparison with diazepam and phenobarbital. Pharmacol Biochem Behav 27:171-175
220. McKernan RM, Rosahl TW, Reynolds DS et al (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha(1) subtype. Nat Neurosci 3:587-582
221. Meert TF, Colpaert FC (1986) The shock probe conflict procedure. A new assay responsive to benzodiazepines, barbiturates and related compounds. Psychopharmacology (Berl) 88:445-450
222. Mendoza DL, Bravo HL, Swanson HH (1999) Antiagressive and anxiolytic effects of gepirone in mice, and their attenuation by WAY 100635. Pharmacol Biochem Behav 62:499-509
223. 1A agonists by shock intensity. Pharmacol Biochem Behav 46:569-573
224. Mi XJ, Chen SW, Wang WJ et al (2005) Anxiolytic-like effect of paeonol in mice. Pharmacol Biochem Behav 81:683-687
225. Millan MJ, Brocco M, Gobert A et al (2001) Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154, 526 and DMP695: a comparison to other classes of anxiolytic agent. Neuropsychopharmacology 25:585-600
226. Millan MJ, Girardon S, Mullot J et al (2002) Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin(1) (NK1) receptor antagonists. Neuropharmacology 42:677-684
227. Millan MJ, Brocco M, Gobert A et al (2005) Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology 177:U448-U413
228. Mizowaki M, Toriizuka K, Hanawa T (2001) Anxiolytic effect of Kami-Shoyo-San (TJ-24) in mice-possible mediation of neurosteroid synthesis. Life Sci 69:2167-2177
229. Molewijk HE, Vanderpoel AM, Mos J et al (1995) Conditioned ultrasonic distress vocalizations in adult male-rats as a behavioral paradigm for screening anti-panic drugs. Psychopharmacology 117:32-40
230. Molina-Hernández M, Tellez-Alcántara NP, García JP et al (2004) Anxiolytic-like actions of leaves of Casimiroa edulis (Rutaceae) in male Wistar rats. J Ethnopharmacol 93:93-98
231. Mora S, Diaz-Veliz G, Millan R et al (2005) Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from aloysia polystachya in rats. Pharmacol Biochem Behav 82:373-378
232. Mora S, Millan R, Lungenstrass H et al (2006) The hydroalcoholic extract of salvia elegans induces anxiolytic-and antidepressant-like effects in rats. J Ethnopharmacol 106:76-81
233. Moreira FA, Aguiar DC, Guimarães FS (2006) Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuropsychopharmacol Biol Psychiat 30:1466-1471
234. Moser PC (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology (Berl) 99:48-53
235. Moser PC, Tricklebank MD, Middlemiss DN (1990) Characterization of MDL 73005EF as a 5-HT 1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol 99:343-349
236. Motta V, Maisonnette S, Morato S (1992) Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze. Psychopharmacology (Berl) 107:135-139
237. Naderi N, Haghparast A, Saber-Tehrani A et al (2008) Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice. Pharmacol Biochem Behav 89:64-75
238. Naito H, Nakamura A, Inoue M et al (2003) Effect of anxiolytic drugs on air-puff-elicited ultrasonic vocalization in adult rats. Exp Anim 52:409-414
239. Nevins ME, Anthony EW (1994) Antagonists at the serotonin-3 receptor can reduce the fear potentiated startle response in the rat: evidence for difference types of anxiolytic activity? J Pharmacol Exp Ther 268:6
240. Nicolas LB, Kolb Y, Prinssen EPM (2006) A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur J Pharmacol 547:106-115
241. Nielsen CK, Sanchez C (1995) Effect of chronic diazepam treatment on foot shock-induced ultrasonic vocalization in adult male rats. Pharmacol Toxicol 77:177-181
242. Njung'e K, Handley SL (1991a) Evaluation of marble burying as a model of anxiety. Pharmacol Biochem Behav 38:63-67
243. Njung'e K, Handley SL (1991b) Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by moce; a putative test for anxiolytic agents. Br J Pharmacol 104:105-112
244. Noirot E (1972) Ultrasounds and material behavior in small rodents. Dev Psychobiol 5:371-387
245. Olajide D, Lader M (1984) A double-blind comparison of buspirone and diazepam in outpatients with chronic anxiety states. Abstract at C.I.N.P. meeting, Florence
246. Olivier B, Molewijk E, van Oorschot R et al (1998) Ultrasonic vocalizations in rat pups: effects of serotonergic ligands. Neurosci Biobehav Rev 23:215-227
247. Onaivi ES, Martin BR (1989) Neuropharmacological and physiological validation of a computercontrolled two compartment black and white box for the assessment of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 13:963-976
248. Papp M, Litwa E, Gruca P et al (2006) Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav Pharmacol 17:9-18
249. Park JH, Cha HY, Seo JJ et al (2005) Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng. Prog Neuropsychopharmacol Biol Psychiatry 29:895-900
250. Paschall GY, Davis M (2002) Olfactory-mediated fear-potentiated startle. Behav Neurosci 116:4-12
251. Paslawski T, Treit D, Baker GB et al (1996) The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) 127:19-24
252. Pecknold JC, Familamiri P, Chang H et al (1985) Buspirone: anxiolytic? Prog Neuropsychopharmacol Biol Psychiatry 9:639-642
253. Pellow S (1986) Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Meth Find Expt Clin Pharmacol 8:557-565
254. Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525-529
255. Pellow S, File SE (1987) Can antipanic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex? Neuropsychobiology 17:5
256. Pellow S, Chopin P, File SE et al (1985) Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167
257. Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39:917-928
258. Peng WH, Wu CR, Chen CS et al (2004) Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors. Life Sci 75:2451-2462
259. Penner MR, McFadyen MP, Carrey N et al (2001) Effects of chronic and acute methylphenidate hydrochloride (Ritalin) administration on locomotor activity, ultrasonic vocalizations, and neuromotor development in 3-to 11-day-old CD-1 mouse pups. Dev Psychobiol 39:216-228
260. Perrine SA, Hoshaw BA, Unterwald EM (2006) Delta opioid receptor ligands modulate anxietylike behaviors in the rat. Br J Pharmacol 147:864-872
261. Picazo O, Lopez-Rubalcava C, Fernandez-Guasti A (1995) Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino)tetralin and ipsabirone in the social interaction paradigm: evidence of a presynaptic action. Brain Res Bull 37:6
262. Picazo O, Estrada-Camarena E, Hemandez-Aragon A (2006) Influence of the post-ovariectomy time framep on the experimental anxiety and the behavioural actions of some anxiolytic agents. Eur J Pharmacol 530:88-94
263. Pich E, Samanin R (1986) Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine. Psychopharmacology (Berl) 89:125-130
264. Pietraszek M, Sukhanov I, Maciejak P et al (2005) Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol 514:25-34
265. Pinel JPJ, Treit D (1978) Burying as a defensive response in rats. J Comp Physiol Psychol 92: 708-712
266. Pletscher A (1991) The discovery of antidepressants-a winding path. Experiencia 47:4-8
267. Podhorna J, Brown RE (2000) Flibanserin has anxiolytic effects without locomotor side effects in the infant rat ultrasonic vocalization model of anxiety. Br J Pharmacol 130:739-746
268. Pokk P, Zharkovsky A (1998) The effects of buspirone on the behaviour of control and stressed mice. J Physiol Pharmacol 49:175-185
269. Pollier F, Sarre S, Aguerre S et al (2000) Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology 22:64-76
270. Popik P, Vetulani J (1993) Similar action of imipramine and arginine-vasopressin in the social interaction test. Pol J Pharmacol 45:2
271. Popik P, Kostakis E, Krawczyk M et al (2006) The anxioselective agent 7-(2-chloropyridin-4-yl) pyrazolo-[1, 5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors. J Pharmacol Exp Ther 319:1244-1252
272. Rabbani M, Sajjadi SE, Zarei HR (2003) Anxiolytic effects of Stachys lavandulifolia Vahl on the elevated plus-maze model of anxiety in mice. J Ethnopharmacol 89(2-3):271-276
273. Rabbani M, Sajjadi SE, Vaseghi G et al (2004) Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice. Fitoterapia 75(5):457-464
274. Rabbani M, Sajjadi SE, Jafarian A et al (2005) Anxiolytic effects of Salvia reuterana Boiss. on the elevated plus-maze model of anxiety in mice. J Ethnopharmacol 101:100-103
275. Rex A, Voigt JP, Gustedt C et al (2004) Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test. Psychopharmacology 177:23-34
276. Richardson R, Vishney A, Lee J (1999) Conditioned odor potentiation of startle in rats. Behav Neurosci 113:787-794
277. Risbrough VB, Geyer MA (2005) Anxiogenic treatments do not increase fear-potentiated startle in mice. Biol Psychiatry 57:33-43
278. Risbrough VB, Brodkin JD, Geyer MA (2003) GABA-A and 5-HTIA receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology 28:654-663
279. Rocha B, Rigo M, Di Scala G et al (1994) Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels. Eur J Pharmacol 262:125-131
280. Rocha VM, Calil CM, Ferreira R et al (2007) Influence of anabolic steroid on anxiety levels in sedentary male rats. Stress Int J Biol Stress 10:326-331
281. Rodgers RJ, Cutler MG, Jackson JE (1997a) Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. II. The elevated plus-maze. Pharmacol Biochem Behav 56: 295-303
282. Rodgers RJ, Cutler MG, Jackson JE (1997b) Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze. Pharmacol Biochem Behav 57:127-136
283. Rohmer JG, Di Scala G, Sandner G (1990) Behavioral analysis of the effects of benzodiazepine receptor ligands in the conditioned burying paradigm. Behav Brain Res 38:45-54
284. Rowlett JK, Tornatzky W, Cook JM et al (2001) Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-carboline-3-carboxylate-t-butyl ester (beta-CCt). J Pharmacol Exp Ther 297:247-253
285. Rudzik AD, Hester JB, Tang AH et al (1973) Triazolobenzodiazepines, a new class of central nervous system depressant compounds. In: Mussini E, Randall LO (eds) The Benzodiazepines. Raven Press, New York, pp 285-326
286. Sakaue M, Ago Y, Sowa C et al (2003) The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze. Eur J Pharmacol 458:141-144
287. Salome N, Stemmelin J, Cohen C et al (2006) Selective blockade of NK2 or NK3 receptors produces anxiolytic-and antidepressant-like effects in gerbils. Pharmacol Biochem Behav 83:533-539
288. Sanchez C (2003) Stress-induced vocalisation in adult animals. A valid model of anxiety? Eur J Pharmacol 463:133-143
289. Sanchez C, Meier E (1997) Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology 129:97-205
290. Sanchez C, Arnt J, Moltzen E (1996) Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models. Eur J Pharmacol 315:245-254
291. Sanger DJ (1990) Effects of buspirone and related compounds on suppressed operant responding in rats. J Pharmacol Exp Ther 254:420-426
292. Sanger DJ (1992) Increased rates of responding produced by buspirone-like compounds in rats. J Pharmacol Exp Ther 261:513-517
293. Santos JM, Gargaro AC, Oliveira AR et al (2005) Pharmacological dissociation of moderate and high contextual fear as assessed by freezing behavior and fear-potentiated startle. Eur Neuropsychopharmacol 15:239-246
294. Savić MM, Obradović DI, Ugresić ND et al (2004) Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt. Pharmacol Biochem Behav 79:279-290
295. Schefke DM, Fontana DJ, Commissaris RJ (1989) Anti-conflict efficacy of buspirone following acute versus chronic treatment. Psychopharmacology (Berl) 99:427-429
296. Schreiber R, Melon C, De Vry J (1998) The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology 135:383-391
297. Schulz B, Fendt M, Gasparini F et al (2001) The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology 41:1-7
298. Seo JJ, Lee SH, Lee YS et al (2007) Anxiolytic-like effects of obovatol isolated from magnolia obovata: involvement of GABA. Prog Neuropsychopharmacol Biol Psychiatry 31:1363-1369
299. Serradeil-Le Gal C, Wagnon J, Tonnerre B et al (2005) An overview of SSR149415, a selective nonpeptide vasopressin V-1b receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev 11:53-68
300. Sheehan DV, Raj AB, Sheehan KH et al (1988) The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report. Pharmacol Biochem Behav 29:815-817
301. Sheehan DV, Raj AB, Sheehan KH et al (1990) Is buspirone effective for panic disorder? J Clin Psychopharmacol 10:3-11
302. Shimada T, Matsumoto K, Osanai M et al (1995) The modified light/dark transition test in mice, evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 26:5
303. Si WC, Xiao JM, Rui W et al (2005) Behavioral effects of sinomenine in murine models of anxiety. Life Sci 78:232-238
304. Siemiatkowski M, Maciejak P, Sienkiewicz-Jarosz H et al (2001) Opposite effects of olanzapine and haloperidol in rat ultrasonic vocalization test. Pol J Pharmacol 53:669-673
305. Sikiric P, Jelovac N, Jelovac-Gjeldum A et al (2001) Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light. Acta Pharmacologica Sinica 22:225-230
306. Silva RCB, Brandao ML (2000) Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav. 65:209-216
307. Silva MTA, Alves CRR, Santarem EMM (1999) Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze. Braz J Med Biol Res 32:333-339
308. Soderpalm B, Hjorth S, Engel JA (1989) Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259-265
309. Soderpalm B, Lundin B, Hjorth S (1993) Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic treatment. Eur J Pharmacol 239:69-73
310. Soman I, Mengi SA, Kasture SB (2004) Effect of leaves of Butea frondosa on stress, anxiety, and cognition in rats. Pharmacol Biochem Behav 79(1):11-16
311. Sommermeyer H, Schreiber R, Greuel JM et al (1993) Anxiolytic effects of the 5-HT1A receptor agonist ipsapirone in the rat: neurobiological correlates. Eur J Pharmacol 240:29-37
312. Starr KR, Price GW, Watson JM et al (2007) SB-649915-B, a novel 5-HT1A. Neuropsychopharmacology 32:2163-2172
313. Stefanski R, Palejko W, Kotowski W (1992) The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety. Neuropharmacology (Berl) 31:1252-1258
314. Stemmelin J, Cohen C, Terranova JP et al (2008) Stimulation of the beta(3)-adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology 33:574-587
315. Tatarczyńska E, Kłodzińska A, Stachowicz K et al (2004) Effects of a selective 5-HT1B receptor agonist and antagonists in animalmodels of anxiety and depression. Behav Pharmacol 15:523-534
316. Tizzano JP, Griffey KI, Schoepp DD (2002) The anxiolytic action of mGlu2. Pharmacol Biochem Behav 73:367-374
317. Tokumo K, Tamura N, Hirai T et al (2006) Effects of (Z)-3-hexenol, a major component of green odor, on anxiety-related behavior of the mouse in an elevated plus-maze test and biogenic amines and their metabolites in the brain. Behav Brain Res 166:247-252
318. Treit D (1985a) Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9:203-222
319. Treit D (1985b) The inhibitory effect of diazepam on defensive burying: anxiolytic vs analgesic effects. Pharmacol Biochem Behav 22:47-52
320. Treit D (1987) Ro 15-1788, CGS8216, picrotoxin, and pentyleneterazol: do they antagonize anxiolytic drug effects through an anxiogenic action? Brain Res Bull 19:401-405
321. Treit D (1990) A comparison of anxiolytic and nonanxiolytic agents in the shock probe burying test for anxiolytics. Pharmacol Biochem Behav 36:203-205
322. Treit D, Fundytus M (1988) A comparison of buspirone and chlordiazepoxide in the shock probe burying test for anxiolytics. Pharmacol Biochem Behav 30:1071-1075
323. Treit D, Pinel JP, Fibiger HC (1981) Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15:619-626
324. Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463-469
325. Treit D, Menard J, Pesold C (1994) The shock probe burying test. Neurosci Protocols Mod 3:9-17
326. Treit D, Degroot A, Kashluba S, Bartoszyk GD (2001) Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test. Eur J Pharmacol 414:245-248
327. Treit D, Degroot A, Shah A (2003) Animal models of anxiety and anxiolytic drug action. In: Kasper S, den Boer JA, Ad Sitsen JM (eds) Handbook of depression and anxiety: a biological approach. New York, Marcel Dekker, pp 681-702
328. Tsuda A, Ida Y, Tanaka M (1988) The contrasting effects of diazepam and yohimbine on conditioned defensive burying in rats. Psychobiology 16:213-217
329. Tyrer P, Tyrer J (1994) Antidepressive drugs for treatment of anxiety disorders-and vice versa. In: den Boer JA, Ad Sitsen JM (eds) Handbook of depression and anxiety: a biological approach. New York, Marcel Dekker, pp 497-514
330. Uriguen L, Perez-Rial S, Ledent C, Palomo T, Manzanares J (2004) Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46:966-973
331. Vaidya AH, Rosenthal DI, Lang W et al (2005) Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action. Meth Find Exp Clin Pharmacol 27:245-255
332. Vargas KM, Da Cunha C, Andreatini R (2006) Amphetamine and pentylenetetrazole given posttrial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plusmaze in mice. Prog Neuropsychopharmacol Biol Psychiatry 30:1394-1402
333. Vigliecca NS, Molina SC, Peñalva MC (2007) A panic experimental model: validation of a complex operant behavioral method in undernourished rats, with desipramine to provide a template effect profile. J Pharmacol Toxicol Method 55:49-57
334. Vignes M, Maurice T, Lante F et al (2006) Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res 1110:102-115
335. Violle N, Messaoudi M, Lefranc-Millot C et al (2006) Ethological comparison of the effects of a bovine alpha(s1)-casein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety. Pharmacol Biochem Behav 84:517-523
336. Vis P, Della Pasqua O, Kruk M et al (2001) Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-MT1A receptor agonist, using a behavioural model in rats. Eur J Pharmacol 414:233-243
337. Vivian JA, Miczek KA (1993) Diazepam and gepirone selectively attenuate either 20-32 or 32-64 kHz ultrasonic vocalizations during aggressive encounters. Psychopharmacology 112:66-73
338. Walker DL, Davis M (1997) Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiat 42:461-471
339. Walker DL, Davis M (2002) Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology 159:304-310
340. Wei XY, Yang JY, Wang JH et al (2007) Anxiolytic effect of saponins from panax quinquefolium in mice. J Ethnopharmacol 111:613-618
341. Weissman BA, Barrett JE, Brady LS et al (1984) Behavioral and neurochemical studies on the anticonflict actions of buspirone. Drug Dev Res 4:83-93
342. Wesolowska A, Nikiforuk A (2007) Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52:1274-1283
343. Wesolowska A, Nikiforuk A, Stachowicz K et al (2006) Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51:578-586
344. Wesołowska A, Paluchowska M, Chojnacka-Wójcik E (2003) Involvement of presynaptic 5-HT (1A) and benzodiazepine receptors in the anticonflict activity of 5-HT(1A) receptor antagonists. Eur J Pharmacol 471:27-34
345. Westen D, Rosenthal R (2003) Quantifying construct validity: two simple measures. JPSP 84: 608-618
346. Wheatley D (1982) Buspirone: multicenter efficacy study. J Clin Psychiat 43:92-94
347. Wilson MA, Burghardt PR, Ford KA et al (2004) Anxiolytic effects of diazepam and ethanol in two behavioral models: comparison of males and females. Pharmacol Biochem Behav 78: 445-458
348. Winslow JT, Noble PL, DavisM(2007) Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. Biol Psychiatry 61:389-395
349. Witkin JM, Perez LA (1990) Comparison of anticonflict effects of buspirone and gepirone with benzodiazepines and antagonists of dopamine and serotonergic receptors in rats. Behav Pharmacol 1:247-254
350. Wood MD, Reavill C, Trail B et al (2001) SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 41:186-199
351. Xu L, Anwyl R, DeVry J et al (1997) Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect. Eur J Pharmacol 323:59-68
352. Yamashita S, Oishi R, Gomita Y (1995) Anticonflict effects of acute and chronic treatments with buspirone and gepirone in rats. Pharmacol Biochem Behav 50:477-479
353. Yasui M, Kato A, Kanemasa T et al (2005) Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes. Nihon Shinkei Seishin Yakurigaku Zasshi 25(3):143-151
354. Yoon BH, Jung JW, Lee JJ et al (2007) Anxiolytic-like effects of sinapic acid in mice. Life Sci 81:234-240
355. Young R, Johnson DN (1991a) A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40:739-743
356. Young R, Johnson DN (1991b) Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test. Pharmacol Biochem Behav 40:733-737
357. Young R, Urbancic A, Emrey TA et al (1987) Behavioral effects of several anxiolytics and putative anxiolytics. Eur J Pharmacol 143:361-371
358. Young R, Batkai S, Dukat M et al (2006) TDIQ (5, 6, 7, 8-tetrahydro-1, 3-dioxolo[4, 5-g] isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice. Pharmacol Biochem Behav 84:62-73
359. Zanoli P, Rivasi M, BaraldiM(2002) Pharmacological activity of hyperforin acetate in rats. Behav Pharmacol 13:645-651